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Production and hosting by ElsevierAbstract Sixty-nine years old lady presented with sudden cardiac arrest, she was found to have
hypertrophic obstructive cardiomyopathy, she refused septal myomectomy and had a dual chamber
ICD implanted, she was put on right ventricular apical pacing with short AV interval, after pacing
her max pressure gradient across left ventricular out ﬂow tract (LVOT) dropped from 117 mmHg
to 21 mmHg and her symptoms much improved over a follow up period of 1 year.
ª 2009 King Saud University. All rights reserved.Introduction
Hypertrophic cardiomyopathy is an inherited cardiac muscle
disorder that affects sarcomeric proteins (McKenna and Behr,
2002). It is genetically transmitted as an autosomal dominant
trait, although a high proportion of sporadic non familial cases
are also known (McKenna and Behr, 2002). Mutations are
chieﬂy in the gene coding for beta cardiac myosin heavy chain
(McKenna et al., 1981). Most patients are young but hyperten-
sion induced severe hypertrophy leading to left ventricular out-
ﬂow tract obstruction is also seen in middle aged and elderly
subjects. Management of hypertrophic cardiomyopathyremains an important clinical challenge because of scarcity of
data from randomized double blind trials (Frank et al., 1978;
McIntosh and Maron, 1988). Furthermore, most trials have
studied young patients rather than the elderly. The Gold stan-
dard for relief of outﬂow tract obstruction remains surgical
myomectomy (McIntosh and Maron, 1988; Cooley et al.,
1976) also phenol ablation of the ﬁrst septal perforator is
increasingly being performed, however dual chamber pacemak-
ers are currently being used in drug refractory hypertrophic
obstructive cardiomyopathy to reduce pressure gradient, hence
improve symptoms, although it is a class II b in the guidelines
(Jeanrenaud et al., 1992; Fananapazir et al., 1992; ACC/AHA/
NASPE, 2002) it sometimes works (see Figs. 1 and 2).
We report a similar case of hypertrophic obstructive cardio-
myopathy (HOCM)with dual chamber ICDwho had decreased
symptoms afterRVapical pacing and decreasedmaximumpres-
sure gradient across left ventricular out ﬂow tract.
Case summary
The patient is a 69 years old Emirates national leading a
predominantly bed bound life. She was diagnosed to have
Figure 1 Maximum pressure gradient across LVOT before pacing.
Figure 2 Maximum pressure gradient across LVOT after pacing.
166 Q. Zaidi et al.essential hypertension and bronchial asthma for 12 years and
suffered from paroxysmal atrial ﬁbrillation. She was investi-
gated for recurrent palpitations and dyspnoea in another cen-
tre and was found to have normal coronary arteries by
angiography in 2004.
In March 2006 she presented with fast atrial ﬁbrillation and
New York Heart Association (NYHA) class II heart failure.
As inpatient, she suffered from recurrent attacks of ventricular
ﬁbrillation leading to cardiac arrest and syncope. These attacks
were refractory to amiodarone therapy and patient needed re-
peated direct current (DC) cardioversion. During that admis-
sion, the transthoracic echocardiogram was suggestive of
HOCM; hence she was referred to our centre (tertiary care)
for evaluation and further management. After transfer the fol-
lowing work up was done:The ECG showed; severe left ventricular hypertrophy by
voltage criteria but no other abnormality.
Transthoracic echocardiogram: Systolic anterior motion of
the anterior mitral leaﬂet. Sever concentric left ventricular
hypertrophy, subvalvular systolic ‘‘dynamic’’ LVOT obstruc-
tion with maximum pressure gradient of 117 mmHg, moderate
to severe pulmonary incompetence and moderate mitral
incompetence.
Transoesophageal echocardiogram: Trileaﬂet sclerotic aortic
valve, conﬁrming subvalvular stenosis, excluding aortic valve
involvement as the echogenicity in the transthoracic echocar-
diogram was suboptimal Septal myomectomy was offered to
the patient and her family and they were explained risks and
beneﬁts for procedure. However the patient was unwilling to
under go any open heart surgery. On 16/04/2007, under aseptic
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was implanted in the left pectoral groove and the A-V delay
was kept at 100 ms to ensure continuous pacing capture. There
were no post operative complications,. The patient was dis-
charged with pacemaker clinic appointment. Amiodarone
was continued with anti hypertensive therapy.
At 7 month follow up the patient reported subjective
improvement in quality of life and decreased dyspnea and
there were no further complaints of palpitation. Also There
were no shocks delivered as per the ICD interrogation At 8
months follow up, patient was reviewed and pacemaker setting
was kept on DDDR mode with a low rate of 60/min and high
rate of 120 bpm and maximum sensor rate of 120 bpm and a
short AV delay of 100 ms.
At 1 year follow up (April 2007) maximum pressure gradi-
ent across LVOT by transthoracic echocardiogram had been
reduced to 21 mmHg. Also at 1 year follow up patient was
found to be in sinus rhythm, free of palpitations and no shocks
delivered for any malignant arrhythmias.
Comment
To the best of our knowledge, this is the ﬁrst reported case of
hypertrophic obstructive cardiomyopathy, who responded to
dual chamber pacing in UAE. Although we relied on subjec-
tive improvement and the drop in pressure gradient, it is clear
that there was a considerable gradient reduction in this patient
and life threatening arrhythmias did not recur. Aim of the ICD
implantation was for secondary prevention of sudden cardiac
arrest and this was achieved. The crucial requirement for suc-
cess of this treatment is complete right ventricular apical cap-
ture which was facilitated by the short of A-V delay and the
apical location of the RV shock/pacing lead.
To date, none of the studies published are able to prove a
correlation between gradient reduction and symptom improve-
ment. Hence pressure gradient reduction by pacing is not the
only factor which explains efﬁcacy of pacing in this patient.
Several mechanisms have been proposed as to the cause of
improvement after pacing. The commonest is the mechanical
beneﬁt of limiting outﬂow tract obstruction by asynchronous
septal activation. An alternative hypothesis is that pacing in-
duced asynchrony results in net contractile depression and
right ward shift of the end systolic pressure–volume relations.Further large randomized controlled trials may be helpful
in determining the exact role played by pacing especially in
older age group of patients.
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